Clinical Trial Update: Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating stereotactic body radiation therapy for oligoprogression in metastatic renal cell carcinoma patients treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Yale University | Conditions: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 2 | Status: RECRUITING